Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
cholestasis/carbohydrate
Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 107 rezultatus
Intestinal capacity to digest and absorb carbohydrates is maintained in a rat model of cholestasis.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Cholestasis is associated with systemic accumulation of bile salts and with deficiency of bile in the intestinal lumen. During the past years bile salts have been identified as signaling molecules that regulate lipid, glucose, and energy metabolism. Bile salts have also been shown to activate
[Carbohydrate metabolism during cholestasis in pregnancy].
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Blood glucose levels were measured in fasting state and 2 hours after breakfast, together with glucose tolerance tests (after a load of 100 g of glucose) and 24-hour glycaemia profile in pregnant women with intrahepatic cholestasis of pregnancy in the third trimester of pregnancy. In all these tests
Carbohydrate metabolism in the course of intrahepatic cholestasis in pregnancy.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Glucose metabolism was evaluated in pregnant women with clinically and biochemically demonstrated intrahepatic cholestasis. Laboratory investigations included measurements of serum glucose concentrations on fasting and 2 hours after breakfast, the glucose tolerance test (100 gm oral glucose load),
Changes in the acinar distribution of some enzymes involved in carbohydrate metabolism in rat liver parenchyma after experimentally induced cholestasis.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Extrahepatic cholestasis induced by ligation and transsection of the common bile duct caused a change in the parenchyma/stroma relationship in rat liver. Two weeks after ligation, the periportal zones of the parenchyma were progressively invaded by expanding bile ductules with surrounding connective
Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Stearoyl-coenzyme A desaturase 1-deficient (SCD1(-/-)) mice have impaired MUFA synthesis. When maintained on a very low-fat (VLF) diet, SCD1(-/-) mice developed severe hypercholesterolemia, characterized by an increase in apolipoprotein B (apoB)-containing lipoproteins and the appearance of
[ANIT cholestasis in the rat liver: effect of glucocorticoid administration on the metabolites of carbohydrate metabolism].
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
[Role of carbohydrates in the development of cholestasis during total parenteral feeding].
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes?
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
OBJECTIVE
Patients with lymphoedema cholestasis syndrome 1/Aagenaes Syndrome need a fat reduced diet when cholestatic. We wanted to assess the need for dietary counselling outside cholestatic episodes, and hypothetized that no counselling was needed.
METHODS
Fifteen patients above 10 years of age
Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND
Carbohydrate antigen 19-9 (CA 19-9) is the serum marker used to diagnose cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC).
OBJECTIVE
We investigated long-term outcomes in patients with PSC and elevated CA 19-9 levels without CCA.
METHODS
A total of 166 PSC
Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND
Biological markers for chronic alcohol consumption like MCV or gammaGT or carbohydrate deficient transferrin (CDT) are useful, but far from being perfect. In patients with liver disease a reliable marker for chronic alcohol consumption as the underlying etiology is highly needed.
Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND
Parenteral nutrition-associated cholestasis (PNAC) is a complication of long-term parenteral nutrition (PN). Removal of lipids may reverse PNAC but compromises the energy to ensure infant growth. The purpose of this study was to test whether a low-fat, high-carbohydrate PN regimen, which
Study of the tumor marker carbohydrate antigen 50 in liver cirrhosis. Pathogenetic considerations.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Carbohydrate antigen 50 (CA 50) is a tumor marker that increases in many malignancies, especially in carcinoma of the digestive tract. False-positive results occur in benign liver disease. The behavior of CA 50 in 86 cirrhotic patients was studied, with thorough clinical and laboratory evaluations.
Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Few cases of infantile liver disease associated with mitochondrial DNA (mtDNA) depletion have been reported. Most of the patients died before 1 year of age of severe liver failure. We describe a new case, a 28-month-old child, presenting with cholestasis at age 2 months, complicated by progressive
Serum level of biliary glycoprotein I, a determinant of cholestasis, of similar use as gamma-glutamyltranspeptidase.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Biliary glycoprotein I (BGP I), a constituent of normal bile and serum, is a glycoprotein (mol. wt. approximately 90,000) containing about 40% carbohydrate. Serum BGP I (S-BGP I) was determined by means of a double-antibody radioimmunoassay in patients with liver and gastrointestinal disease and in
The efficacy of the combination of percutaneous transhepatic biliary drainage and 125 I stranded seeds for malignant bile duct obstruction treatment
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Purpose: To investigate the efficacy of percutaneous transhepatic biliary drainage (PTBD) combined with iodine-125 (125I) stranded seeds for the treatment of malignant bile duct obstruction (MBO).
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
